NASDAQ: ORMP ORAMED PHARMACEUTICALS INC. 8-K

Oramed closes sale of Oratech subsidiary for 50% stake in Lifeward, invests $9M more

Filed March 31, 2026 · Period ending March 25, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ORMP commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 10:01 PM